| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 870 | 0 | 1.445 | 24.541 | 31.039 | 33.197 | 35.190 | 63.650 | 101.485 | 62.506 |
| Total Income - EUR | 870 | 0 | 1.445 | 24.541 | 31.039 | 33.197 | 35.190 | 63.650 | 101.485 | 62.506 |
| Total Expenses - EUR | 701 | 567 | 0 | 17.515 | 27.670 | 34.127 | 25.643 | 58.163 | 78.233 | 79.484 |
| Gross Profit/Loss - EUR | 169 | -567 | 1.445 | 7.025 | 3.369 | -930 | 9.547 | 5.487 | 23.252 | -16.977 |
| Net Profit/Loss - EUR | 142 | -567 | 1.402 | 6.780 | 3.058 | -1.262 | 9.195 | 4.344 | 22.238 | -17.602 |
| Employees | 0 | 0 | 0 | 2 | 2 | 0 | 2 | 0 | 4 | 3 |
Check the financial reports for the company - Symbiotic Consulting Group Europe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 618 | 18 | 1.463 | 9.123 | 12.164 | 10.682 | 19.658 | 26.501 | 60.733 | 42.291 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 694 | 678 | 681 | 2.428 | 2.745 |
| Receivables | 0 | 0 | 1.445 | 0 | 0 | 0 | 5.296 | 5.312 | 5.296 | 5.266 |
| Cash | 618 | 18 | 18 | 9.123 | 12.164 | 9.988 | 13.684 | 20.508 | 53.008 | 34.279 |
| Shareholders Funds | 591 | 18 | 1.420 | 8.174 | 11.074 | 9.602 | 18.584 | 22.986 | 45.153 | 27.299 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26 | 0 | 43 | 949 | 1.091 | 1.080 | 1.073 | 3.515 | 15.579 | 14.992 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6202 - 6202" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Symbiotic Consulting Group Europe S.r.l.